Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,195 | -60,277 | -32,944 | -13,945 | -37,138 |
| Depreciation Amortization | 258 | 173 | 95 | 39 | 109 |
| Accounts receivable | 7 | 407 | 869 | 113 | -1,086 |
| Accounts payable and accrued liabilities | 103 | 618 | 1,143 | 609 | -480 |
| Other Working Capital | 12,817 | 7,621 | 4,875 | -7,476 | -1,327 |
| Other Operating Activity | 13,505 | 10,130 | 1,611 | 1,666 | 11,904 |
| Operating Cash Flow | $-63,505 | $-41,328 | $-24,351 | $-18,994 | $-28,018 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,136 | -946 | -580 | -298 | -204 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -859 |
| Investing Cash Flow | $-1,136 | $-946 | $-580 | $-298 | $-1,063 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 7,338 |
| Debt Repayment | -7,963 | -7,963 | N/A | N/A | N/A |
| Common Stock Issued | 219,165 | 218,659 | 218,626 | 218,574 | 197 |
| Other Financing Activity | 56,492 | 56,493 | 56,493 | 57,748 | 72,351 |
| Financing Cash Flow | $267,694 | $267,189 | $275,119 | $276,322 | $79,886 |
| Beginning Cash Position | 54,201 | 54,201 | 54,201 | 54,201 | 8,371 |
| End Cash Position | 257,254 | 279,116 | 304,389 | 311,231 | 59,176 |
| Net Cash Flow | $203,053 | $224,915 | $250,188 | $257,030 | $50,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,505 | -41,328 | -24,351 | -18,994 | -28,018 |
| Capital Expenditure | -1,136 | -946 | -580 | -298 | -204 |
| Free Cash Flow | -64,641 | -42,274 | -24,931 | -19,292 | -28,222 |